Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
| Autor: | Morris MJ, Pandit-Taskar N, Carrasquillo J, Divgi CR, Slovin S, Kelly WK, Rathkopf D, Gignac GA, Solit D, Schwartz L, Stephenson RD, Hong C, Delacruz A, Curley T, Heller G, Jia X, O'Donoghue J, Larson S, Scher HI, Morris, Michael J |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 5/20/2009, Vol. 27 Issue 15, p2436-2442, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|